Biofil Chemicals opened lower at ₹29.87, compared with its previous close of ₹30.19. During today's session, the stock has traded between ₹29.85 and ₹30.78, with an average traded price of ₹30.22. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Biofil Chemicals is now worth
₹ 4,374.00
resulting in a loss of
₹ 5,626.00 (56.26%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-0.01 (-0.03%)
Day High
₹30.78
Day Low
₹29.85
Day Open
₹29.87
Prev Close
₹30.19
Volume
7,031
Value Traded
₹0.02 Cr
1W Return
1.82%
1M Return
-12.55%
3M Return
-11.39%
6M Return
-9.10%
1Y Return
-26.73%
Market Cap (₹ Cr.)
49
PE Ratio
102.50
PB Ratio
2.32
Dividend Yield
-
ROE
12.92%
ROCE
15.61%
Book Value (₹)
13.25
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
1.82%
6 Week
-
1 Month
-12.55%
3 Month
-11.39%
9 Month
-5.42%
No data available.
Biofil Chemicals AGM passes all resolutions with near-unanimous support
All four AGM resolutions passed with near-unanimous shareholder support. Ashok Kumar Ramawat approved for continuation as Independent Director beyond age 75. FY26 audited financial statements adopted with 99.9998% votes in favour. Related party transactions with Cyano Pharma approved by public shareholders.
19 days agoBiofil Chemicals schedules 41st AGM for Sept 23; seeks ₹20cr RPT approval
Biofil Chemicals schedules 41st AGM for September 23, 2026. Seeks approval for ₹20 crore related party transactions with Cyano Pharma. Re-appointment of Smitesh Shah and continuation of Ashok Kumar Ramawat as independent director.
1mo agoBiofil Chemicals Q1FY27 revenue surges 92%, profit drops 95%
Biofil Chemicals & Pharmaceuticals Limited reported a significant divergence in Q1FY27 results, with revenue rising 92% to ₹1,235.02 lakh while net profit dropped 95% to ₹10.91 lakh. The Chemical Division drove growth with ₹921.62 lakh in revenue, whereas the Pharma Division posted a loss of ₹6.41 lakh. The decline in profitability was further exacerbated by a near-total collapse in other income. The Board approved the results on August 11, 2026, and announced ongoing manufacturing renovations for Schedule M compliance.
2mo agoBiofil Chemicals seeks shareholder nod for director over 75
Biofil Chemicals & Pharmaceuticals Ltd seeks shareholder approval for Mr. Ashok Kumar Ramawat to continue as an Independent Director past age 75. The Board approved the move on August 11, 2026, citing his 46 years of pharmaceutical experience. The resolution requires a Special Resolution at the 41st AGM, complying with SEBI LODR Regulations.
2mo agoBiofil Chemicals FY26 net profit rises to ₹278.60 crore
Biofil Chemicals and Pharmaceuticals Limited reported a net profit of ₹278.60 crore for FY26, up from ₹55.78 crore in FY25, despite a drop in revenue to ₹2839.52 crore. The Board approved the audited results on May 30, 2026, which were subsequently published in newspapers on May 31, 2026.
4mo agoBiofil Chemicals board to meet on May 30 for FY26 results
Biofil Chemicals and Pharmaceuticals Limited announced a board meeting on May 30, 2026, to approve audited financial results for Q4 and FY26. The trading window will reopen 48 hours after the results are declared.
4mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Biofil Chemicals is now worth
₹ 4,374.00
resulting in a loss of
₹ 5,626.00 (56.26%)
Note: Past profits do not guarantee future returns.
